MHP
IRMD icon

Manatuck Hill Partners’s iRadimed IRMD Stock Holding History

Manatuck Hill Partners’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-20,000
Closed -$258K – 96
2014
Q4 		$258K Hold
20,000
– – 0.06% 76
2014
Q3 		$140K Buy
+20,000
New +$181K 0.03% 90

Other funds holding IRMD

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
GMCM
Gruber & McBaine Capital Management San Francisco, California $369M AUM 12.23% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
CIS
Connors Investor Services Wyomissing, Pennsylvania $1.08B AUM 31.31% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Manatuck Hill Partners's IRMD Position: Q1 2015 in Review

Manatuck Hill Partners sold out of iRadimed (IRMD) in Q1 2015, closing a stake of 20,000 shares — an estimated $258K sold.

Manatuck Hill Partners first reported a position in IRMD in Q3 2014 and held it in 2 quarters. The position peaked at $258K in Q4 2014. 21 funds tracked by Wall St. Rank hold IRMD as of Q1 2015.

  • Manatuck Hill Partners reported no remaining iRadimed position as of Q1 2015 after selling out during the quarter.
  • Manatuck Hill Partners sold 20,000 iRadimed shares in Q1 2015, an estimated $258K.
  • Manatuck Hill Partners first reported a position in iRadimed in Q3 2014 and held it in 2 quarters.
  • Manatuck Hill Partners's iRadimed position peaked at $258K in Q4 2014.
  • 21 funds tracked by Wall St. Rank held iRadimed as of Q1 2015.

Based on Manatuck Hill Partners's 13F filing for Q1 2015, filed 15 May 2015.